Will Tesla Go Up or Down in 2025?
The last few months have been exciting for Tesla and…
Sell
36
RHE Quote, Financials, Valuation and Earnings
Last price:
$1.59
Seasonality move
:
22.37%
Day range:
$1.54 - $1.64
52-week range:
$1.13 - $3.08
Dividend yield:
0%
P/E ratio:
0.13x
P/S ratio:
0.17x
P/B ratio:
--
Volume:
3K
Avg. volume:
16.2K
1-year change:
-24.39%
Market cap:
$2.9M
Revenue:
$17.2M
EPS (TTM):
-$1.55
Analysts' Opinion
-
Consensus RatingRegional Health Properties has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Regional Health Properties has an estimated upside of 319.36% from its current price of $1.55.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $1.55.
Fair Value
-
According to the consensus of 0 analysts, Regional Health Properties has 319.36% upside to fair value with a price target of -- per share.
RHE vs. S&P 500
-
Over the past 5 trading days, Regional Health Properties has overperformed the S&P 500 by 2.59% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Regional Health Properties does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Regional Health Properties has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Regional Health Properties reported revenues of $4.2M.
Earnings Growth
-
Regional Health Properties has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Regional Health Properties reported earnings per share of -$0.52.
Enterprise value:
67.7M
EV / Invested capital:
1.54x
Price / LTM sales:
0.17x
EV / EBIT:
--
EV / Revenue:
3.94x
PEG ratio (5yr expected):
--
EV / Free cash flow:
87.98x
Price / Operating cash flow:
3.76x
Enterprise value / EBITDA:
36.96x
Gross Profit (TTM):
$7.2M
Return On Assets:
-4.68%
Net Income Margin (TTM):
-16.79%
Return On Equity:
-489.72%
Return On Invested Capital:
-5.98%
Operating Margin:
-7.1%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $32.2M | $22.8M | $17.2M | $4.1M | $4.2M | |
| Gross Profit | $8.9M | $8.7M | $7.2M | $1.7M | $1.9M | |
| Operating Income | -$3.5M | -$1.1M | -$203K | -$404K | -$300K | |
| EBITDA | -$324K | -$830K | $1.8M | $261K | $169K | |
| Diluted EPS | -$8.05 | $17.35 | -$1.55 | -$0.52 | -$0.52 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $18M | $20.6M | $18.5M | $10.6M | $13.6M | |
| Total Assets | $110.3M | $107M | $95.4M | $64M | $60.1M | |
| Current Liabilities | $4.8M | $7.5M | $9.4M | $7.2M | $11.3M | |
| Total Liabilities | $98.2M | $96.1M | $89.5M | $63.6M | $62.4M | |
| Total Equity | $12.1M | $10.9M | $5.9M | $387K | -$2.4M | |
| Total Debt | $54.8M | $53.4M | $52.6M | $51.4M | $46.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$1.4M | $2M | $1.2M | $505K | -$112K | |
| Cash From Investing | -$187K | -$1M | -$472K | -$62K | -$35K | |
| Cash From Financing | -$2.7M | -$1.8M | -$1.9M | -$673K | $75K | |
| Free Cash Flow | -$1.6M | $1M | $770K | $443K | -$147K | |
RHE
Sector
Market Cap
$2.9M
$45.9M
Price % of 52-Week High
50.41%
46.95%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-24.39%
-32.15%
Beta (5-Year)
0.916
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$1.52
200-day SMA
Sell
Level
$2.12
Bollinger Bands (100)
Sell
Level
1.6 - 1.96
Chaikin Money Flow
Sell
Level
-207.2M
20-day SMA
Sell
Level
$1.60
Relative Strength Index (RSI14)
Sell
Level
46.17
ADX Line
Buy
Level
21.18
Williams %R
Neutral
Level
-55.2632
50-day SMA
Sell
Level
$1.66
MACD (12, 26)
Sell
Level
-0.04
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
473.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-1.3444)
Sell
CA Score
(Annual)
Level (-2.5997)
Buy
Beneish M-Score
(Annual)
Level (-3.8146)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (5.3627)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Regional Health Properties Inc is a self-managed healthcare real estate investment company that invests in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transactions. It has two reportable segments real estate segment and the healthcare services segment. It derives the majority of its revenue from the healthcare services segment. Its portfolio of properties is diversified across various states, with concentrations in Georgia and Ohio.
Stock Forecast FAQ
In the current month, RHE has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RHE average analyst price target in the past 3 months is --.
-
Where Will Regional Health Properties Stock Be In 1 Year?
According to analysts, the consensus estimate is that Regional Health Properties share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Regional Health Properties?
Analysts are divided on their view about Regional Health Properties share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Regional Health Properties is a Sell and believe this share price will drop from its current level to --.
-
What Is Regional Health Properties's Price Target?
The price target for Regional Health Properties over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is RHE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Regional Health Properties is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of RHE?
You can purchase shares of Regional Health Properties via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Regional Health Properties shares.
-
What Is The Regional Health Properties Share Price Today?
Regional Health Properties was last trading at $1.59 per share. This represents the most recent stock quote for Regional Health Properties. Yesterday, Regional Health Properties closed at $1.55 per share.
-
How To Buy Regional Health Properties Stock Online?
In order to purchase Regional Health Properties stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
